Strand Diagnostics, Inc.: Series A $30M

Posted in I - Series A, Q - 1Q12, R - MID WEST, X - Device (Diagnostic), X - Device (Sequencing), XX - IN

Strand Diagnostics (Indianapolis, IN) a commercial-stage molecular diagnostics company focused on DNA screening of breast and prostate biopsy samples and patient DNA for molecular cancer diagnosis verification, closed a $30M Series A financing. Participants include NantWorks. Note: Closing out 1Q deals. Thanx for your patience as we play catch-up.

Jan

2010

Endocyte, Inc.: Series C $26M

Posted in I - Series C, Q - 4Q09, R - MID WEST, X - Oncology, X - Therapeutic Platform, XX - IN

Endocyte (West Lafayette, IN) a clinical-stage biopharmaceutical focused on folate-receptor targeted receptors in ovarian, NSCLC and breast cancers and renal cell carcinoma, closed a $26M Series B financing. Participants include Sanderling Ventures, Burrill & Co., American Bailey Ventures, Blue Chip Venture Co. and Triathlon Medical Ventures. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

to top of page...